Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, AEON Biopharma Inc’s stock clocked out at $0.66, down -7.03% from its previous closing price of $0.71. In other words, the price has decreased by -$7.03 from its previous closing price. On the day, 2.88 million shares were traded.
Ratios:
To gain a deeper understanding of AEON’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.22 and its Current Ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 29 ’24 when Oleg Grodnensky bought 201,825 shares for $2.63 per share.
Stock Price History:
Over the past 52 weeks, AEON has reached a high of $1236.24, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -95.32%, while the 200-Day Moving Average is calculated to be -98.97%.
Shares Statistics:
A total of 1.11M shares are outstanding, with a floating share count of 0.76M. Insiders hold about 31.68% of the company’s shares, while institutions hold 35.11% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
